Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Eli J
Begin reducing refined carbohydrates and sugar without enforcing strict keto limits yet
FDA labeling for the related tesamorelin product recommends IGF-1 monitoring
The clinical characteristics of PD comprise motor disorders, such as static tremor, muscle stiffness, motor retardation, gait disorders and non-motor symptoms, such as reduced sense of smell, mental disorders, sleep disorders, cognitive disorders 3
GHRP-2 is frequently used in scientific studies investigating the mechanisms of hormone release signaling and pituitary pathway regulation
In health professionals who carry out care work, the percentage of carriers can exceed 50%